These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3118057)

  • 1. Treatment of superficial papillary transitional cell carcinoma of the ureter by vesicoureteral reflux of mitomycin C.
    Smith AY; Vitale PJ; Lowe BA; Woodside JR
    J Urol; 1987 Nov; 138(5):1231-3. PubMed ID: 3118057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vesicorenal reflux and upper urinary tract transitional cell carcinoma after transurethral resection of recurrent superficial bladder carcinoma.
    De Torres Mateos JA; Banús Gassol JM; Palou Redorta J; Morote Robles J
    J Urol; 1987 Jul; 138(1):49-51. PubMed ID: 3599219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of urothelial carcinoma of the upper urinary tract following prostatocystectomy with mitomycin C instillation in the ileal loop.
    van Helsdingen PJ; Rikken CH
    J Urol; 1986 Aug; 136(2):461-3. PubMed ID: 3090277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recurrence rate in adjuvant local chemotherapy of bladder cancer with mitomycin C].
    Flüchter SH; Harzmann R; Erdmann D; Bichler KH
    Helv Chir Acta; 1982 Aug; 49(3-4):349-52. PubMed ID: 6813293
    [No Abstract]   [Full Text] [Related]  

  • 6. Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder.
    Kurth KH; Bouffioux C; Sylvester R; de Pauw M
    Prog Clin Biol Res; 1988; 269():525-37. PubMed ID: 3134663
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term intravesical thiotepa treatment in patients with superficial bladder tumors and vesicoureteral reflux.
    Nissenkorn I; Servadio C; Vilikowski E; Glanz I
    J Urol; 1985 Feb; 133(2):198-9. PubMed ID: 3918177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urothelial neoplasia as a late complication of transitional-cell carcinoma of the bladder].
    Petta S; Bilotta L; Pacchiele R; Palleschi G; Aloisi P
    Arch Ital Urol Androl; 1998 Jun; 70(3 Suppl):55-8. PubMed ID: 9707773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Four cases of upper urinary tract transitional cell carcinoma after radical cystectomy in bladder cancer].
    Nishio Y; Kaku S; Hida S; Ohishi K; Okada Y; Yoshida O
    Hinyokika Kiyo; 1988 Sep; 34(9):1593-9. PubMed ID: 3213794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical trials with localized mitomycin instillation therapy for superficial urothelial bladder carcinoma].
    Flüchter SH; Bichler KH; Harzmann R; Erdmann D
    Onkologie; 1982 Feb; 5(1):42-5. PubMed ID: 6803202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of intravesical mitomycin C in the treatment of superficial transitional cell carcinoma of the urinary bladder.
    Pavlotsky A; Eidelman A; Barak F; Alon H; Horn Y
    J Surg Oncol; 1989 May; 41(1):9-11. PubMed ID: 2497274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence of superficial bladder carcinoma after intravesical instillation of mitomycin-C. Comparison of exposure times.
    Giesbers AA; Van Helsdingen PJ; Kramer AE
    Br J Urol; 1989 Feb; 63(2):176-9. PubMed ID: 2495144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of intravesical cisplatin and mitomycin-C for recurrent transitional cell carcinoma of bladder refractory to thiotepa.
    Mobley WC; Loening SA; Narayana AS; Culp DA
    Urology; 1986 Apr; 27(4):335-9. PubMed ID: 3083555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ureteral stump transitional cell carcinoma in a patient with recurrent superficial bladder cancer: an argument for complete nephroureterectomy in selected patients.
    Klee LW; Adams MC; Foster RS
    J Urol; 1990 Oct; 144(4):972-3. PubMed ID: 2204733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCG-(RIVM) versus mitomycin intravesical therapy in patients with superficial bladder cancer. EORTC GU Group and the Dutch South-East Collaborative Group.
    Debruyne FM; van der Meijden AP; Franssen MP
    Prog Clin Biol Res; 1989; 303():435-46. PubMed ID: 2506556
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravesical thiotepa and mitomycin C treatment immediately after transurethral resection and later for superficial (stages Ta and Tis) bladder cancer: a prospective, randomized, stratified study with crossover design.
    Zincke H; Benson RC; Hilton JF; Taylor WF
    J Urol; 1985 Dec; 134(6):1110-4. PubMed ID: 3932685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of superficial bladder cancer in a community setting.
    Haas JA
    Urology; 1985 Oct; 26(4 Suppl):51-4. PubMed ID: 3931328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bladder wall calcification after topical mitomycin C.
    Alter AJ; Malek GH
    J Urol; 1987 Nov; 138(5):1239-40. PubMed ID: 3118058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe bladder contracture in patient receiving intravesical mitomycin C for superficial bladder cancer.
    Baker WC; Russo MA; deVere White RW
    Urology; 1987 Oct; 30(4):357-8. PubMed ID: 3116739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravesical mitomycin C for carcinoma in situ of the urinary bladder.
    Hellsten S; Månsson W; Henrikson H; Idwall I; Lindholm K; Mikulowski P; Mårtensson S; Oldbring J
    Scand J Urol Nephrol; 1990; 24(1):35-8. PubMed ID: 2108491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.